ArticleJournal of clinical medicine2025
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group.
Abstract read
In one paragraph
Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparative outcomes of neoadjuvant chemotherapy versus upfront surgical resection in osteosarcoma: a systematic review and meta-analysis.World journal of surgical oncology · 2025Pooled it
- Routine Laboratory Biomarkers for Survival Prediction After Limb-Salvage Surgery in Osteosarcoma: Development of a LASSO-Cox Prognostic Model and Internal Validation.Journal of clinical medicine · 2026Article
- Selenium-Loaded Calcium Phosphate with Long-Term and Curative Dosage Drug Release for Post-Surgical Osteosarcoma Management and Osteogenesis.International journal of molecular sciences · 2026Article
- Pathologic fracture following neoadjuvant therapy: a paradoxical radiological sign of effective treatment response.Skeletal radiology · 2026Article
- Prognostic factors and survival outcomes in patients undergoing limb-sparing surgery for primary malignant bone tumors.Frontiers in oncology · 2026Article
- Time-dependent evolution of osteosarcoma recurrence risk across clinical risk stratification and its prognostic value.American journal of cancer research · 2026Article
- QuantitativeQuantitative imaging in medicine and surgery · 2026Article
- AnOncology research · 2026Article
- Research Progress on the Evaluation and Clinical Value of Negative Surgical Margins in Osteosarcoma.Orthopedic research and reviews · 2026Review
- Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications.Biology · 2025Review
- Impact of scaffold material choice on osteosarcoma phenotype and drug responses in 3D.Acta biomaterialia · 2025Article
- Molecular and Glycosylation Pathways in Osteosarcoma: Tumor Microenvironment and Emerging Strategies Toward Personalized Oncology.Current issues in molecular biology · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Nadiye SeverDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0001-7312-3827
Fatih ŞimşekDepartment of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
İlknur Deliktaş OnurDr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.
Hayati ArvasDicle University Faculty of Medicine, Diyarbakır 21300, Turkey.
Tural GuliyevDivision of Medical Oncology, Bezmialem Vakıf University Hospital, İstanbul 34093, Turkey.
Teoman ŞakalarDivision of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş 46050, Turkey.
Ceren Mordağ ÇiçekDivision of Medical Oncology, Pamukkale University Hospital, Pamukkale 20160, Turkey.
Seval OrmanDivision of Medical Oncology, Kartal Training and Research Hospital, İstanbul 34865, Turkey.
Emine Bihter ÇetinDivision of Medical Oncology, Celal Bayar University Hospital, Manisa 45030, Turkey.ORCID 0000-0001-5638-1816
Kamil KayaşGaziantep University Faculty of Medicine, Gaziantep 27410, Turkey.
Sinem AkbaşKoç University Faculty of Medicine, İstanbul 34450, Turkey.ORCID 0000-0002-7197-211X
Yeşim AğyolDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Ali Kaan GürenDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0002-3562-5006
Pınar ErelDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Erkam KocaaslanDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Burak PaçacıDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Mustafa Alperen TunçDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0002-1537-3032
Abdussamet ÇelebiDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Nargiz MajidovaDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0002-2575-5819
Ayşe DurnalıDr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.
Melih ŞimşekDivision of Medical Oncology, Bezmialem Vakıf University Hospital, İstanbul 34093, Turkey.ORCID 0000-0003-0633-8558
Mustafa ŞahbazlarDivision of Medical Oncology, Celal Bayar University Hospital, Manisa 45030, Turkey.
Selver IşıkDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0002-2726-1740
Rukiye ArıkanDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Özlem ErcelepDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.
Murat SarıMedical Oncology, Department of Internal Medicine, İstanbul Medipol University, İstanbul 34810, Turkey.ORCID 0000-0003-0596-1559
Osman KöstekMedical Oncology, Department of Internal Medicine, İstanbul Medipol University, İstanbul 34810, Turkey.
İbrahim Vedat BayoğuDivision of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, İstanbul 34854, Turkey.ORCID 0000-0002-0481-1084
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
neoadjuvant chemotherapyosteosarcomaprognostic factorssurvival analysistumor necrosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.